Treatment linked to the patient’s oncologist
Luminate’s Lotus program works with oncology physicians and insurers to move suitable cancer drug infusions into the home. The patient’s existing clinician continues to prescribe and dispense the medication. Nurses deliver care while the company develops auto-injector and monitoring technologies for patient-led administration.
Clinic partnerships and clinical studies
The new capital supports access to home care through 40 partner oncology clinics and clinical studies of the infusion technologies. Luminate is also testing Lilac and Lily, devices aimed at reducing chemotherapy-related neuropathy and hair loss. At the announcement, these products remained in development and clinical trials.